Amy Rogers,John A. Leake,Nigel J. Clarke,Russell E. Baumann
申请号：
US15811463
公开号：
US20180136211A1
申请日:
2017.11.13
申请国别(地区):
US
年份:
2018
代理人:
摘要：
The present disclosure provides rapid and non-invasive methods for determining whether a patient will benefit from treatment with therapeutic agents that inhibit Hepatitis C virus (HCV). These methods are based on detecting HCV RNA and/or anti-HCV antibodies in small-volume dried biological fluid samples that are collected using a microsampling device. Kits for use in practicing the methods are also provided.
